ESR1 and ovarian carcinoma: ESR1 positive cases (n = 10) in 863 patients tested at the Institute of Pathology, Charité occurred mainly in breast cancer (9/10) and to a lesser degree, in ovarian cancer patients (1/10) (Figure 1b).